AbbVie Inc. officer Nicholas Donoghoe is set to sell 21,082 common shares of the company, with an aggregate market value of approximately $3.72 million, on March 20, 2024. The shares were acquired as performance shares directly from the issuer on February 28, 2024, as part of compensation. There is no reportable history of securities sold by Donoghoe in the past three months prior to this notice dated March 20, 2024.

AbbVie Inc. officer Nicholas Donoghoe is set to sell 21,082 common shares of the company, with an aggregate market value of approximately $3.72 million, on March 20, 2024. The shares were acquired as performance shares directly from the issuer on February 28, 2024, as part of compensation. There is no reportable history of securities sold by Donoghoe in the past three months prior to this notice dated March 20, 2024.